(2021) Should metformin remain the first-line therapy for treatment of type 2 diabetes
At the European Congress on Obesity in 2026, researchers presented a further analysis looking at a specific subgroup of patients
We advise investors to check with certified experts before making any investment Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint
Montelukast , a leukotriene receptor antagonist available on prescription, is sometimes used for allergic rhinitis and asthma
In mice the gallbladder is located in the middle lobe fissure, whereas the rat does not have a gallbladder
#GLP1 #ObesityDrugs #PharmaInnovation #DrugDevelopment #ClinicalResearch #Biopharma #MetabolicDisease #PharmaPipeline #LifeSciences #HealthcareInnovation #pharma #competition #pharmaceuticals #market #scientists #research #development #treatment #obesity To view or add a comment, sign in More Relevant Posts The CEO of Roches, opens new tab Genentech unit, Ashley Magargee, said on Monday the company is striving to build a portfolio of obesity medicines that are both tolerable in terms of side effects and affordable
